(Q38091720)

28 August 2017

title

Bacillus Calmette-Guérin immunotherapy for genitourinary cancer (English)

1 reference

28 August 2017

1 reference

Nilay M Gandhi

1

1 reference

28 August 2017

Alvaro Morales

series ordinal

2

1 reference

28 August 2017

Donald L Lamm

series ordinal

3

1 reference

28 August 2017

publication date

20 March 2013

1 reference

28 August 2017

1 reference

28 August 2017

volume

112

1 reference

28 August 2017

issue

3

1 reference

28 August 2017

page(s)

288-297

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11754.X

28 August 2017

1 reference

Cancer increased after a reduction of infections in the first half of this century in Italy: etiologic and preventive implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11754.X

Effect of Bacillus Calmette-Guérin Infection on Transplanted Tumours in the Mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11754.X

Malignant melanoma metastatic to the bladder. Regression following intratumor injection of BCG vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11754.X

History of bacillus Calmette-Guerin and bladder cancer: an immunotherapy success story

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11754.X

Characterization of the internalization of bacillus Calmette-Guerin by human bladder tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11754.X

Tumor necrosis factor-related apoptosis-inducing ligand: a novel mechanism for Bacillus Calmette-Guérin-induced antitumor activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11754.X

A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guérin for transitional-cell carcinoma of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11754.X

Preventing progression and improving survival with BCG maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11754.X

Intravesical bacillus Calmette-Guerin versus mitomycin C for superficial bladder cancer: a formal meta-analysis of comparative studies on recurrence and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11754.X

An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guérin for non-muscle-invasive bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11754.X

Long-term efficacy results of EORTC genito-urinary group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Guérin, and bacillus Calmette-Guérin plus isoniazid in patients with intermediate- and [...]

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11754.X

Efficacy and safety of bacille Calmette-Guérin immunotherapy in superficial bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11754.X

21 January 2018

Bladder cancer, 1996.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11754.X

Randomized intergroup comparison of bacillus calmette-guerin immunotherapy and mitomycin C chemotherapy prophylaxis in superficial transitional cell carcinoma of the bladder a southwest oncology group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11754.X

Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11754.X

Induction of controlled prostatic tissue necrosis by bacille Calmette-Guérin derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11754.X

21 January 2018

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11754.X

10.1111/J.1464-410X.2012.11754.X

21 January 2018

Identifiers

DOI

1 reference

28 August 2017

1 reference